Importance Myocarditis has been reported with COVID-19 but is not clearly recognized as a
possible adverse event following COVID-19 vaccination. Objective To describe myocarditis …

Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …

Background The coronavirus disease of 2019 (COVID‐19) is a global pandemic with over
266 million cases and 5 million deaths worldwide. Anti‐COVID‐19 vaccinations have had …

Background Myocarditis following coronavirus disease 2019 (COVID-19) mRNA vaccines
(Pfizer-BioNTech and Moderna) has been increasingly reported. Incidence rates in the …

Importance Vaccine-associated myocarditis is an unusual entity that has been described for
the smallpox vaccine, but only anecdotal case reports have been described for other …

Importance Vaccination against COVID-19 provides clear public health benefits, but
vaccination also carries potential risks. The risks and outcomes of myocarditis after COVID …

Background Reports have suggested an association between the development of
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus …

Myocarditis has been recognized as a rare complication of coronavirus disease 2019
(COVID-19) mRNA vaccinations, especially in young adult and adolescent males. According …

The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered
intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is …

Wide availability of the 3 vaccines approved by the US Food and Drug Administration for
emergency use against SARS-CoV-2 has led to reports of adverse reactions not seen during …